Effect of insulin therapy on endothelium-dependent dilation in type 2 diabetes mellitus

American Journal of Cardiology

Volumn 89, Issue 4, 2002, Pages 431-434

  Gaenzer, Hannes ^a   Neumayr, Günther ^a   Marschang, Peter ^a   Sturm, Wolfgang ^a   Lechleitner, Monika ^a   Föger, Bernhard ^a   Kirchmair, Rudolf ^a   Patsch, Josef ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; C REACTIVE PROTEIN; GLUCOSE; HEMOGLOBIN A1C; INSULIN; LIPOPROTEIN; METFORMIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL REACTIVITY; BRACHIAL ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC DIET; DRUG EFFECT; ENDOTHELIUM INJURY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; INSULIN TREATMENT; LIPID BLOOD LEVEL; LIPOPROTEIN METABOLISM; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TREATMENT OUTCOME; ULTRASOUND;

ADULT; AGED; BRACHIAL ARTERY; DIABETES MELLITUS, TYPE 2; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; ULTRASONOGRAPHY, INTERVENTIONAL; VASODILATION;

EID: 0037083222     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(01)02266-4     Document Type: Article

References (30)

1. Vascular thrombosis in type II diabetes mellitus
2. Impaired endothelium-dependent and independent vasodilation in type 2 (non-insulin-dependent) diabetes mellitus
3. Impaired nitric oxide mediated vasodilation in patients with non-insulin-dependent diabetes mellitus
4. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus
5. Insulin and risk of cardiovascular disease: A meta-analysis
6. Improved endothelial function with metformin in type 2 diabetes mellitus
7. Ciprofibrate therapy improves endothelial function and reduces postprandial lipemia and oxidative stress in type 2 diabetes mellitus
8. Effect of oral vitamin E (alpha-tocopherol) supplementation on vascular endothelial function in type 2 diabetes mellitus
9. Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery
10. Insulin therapy improves endothelial function in type 2 diabetes
11. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis
12. Preserved endothelial function in IDDM patients, but not in NIDDM patients, compared with healthy subjects
13. Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants
14. Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance
15. Impaired endothelium-dependent and independent dilatation of forearm resistance arteries in men with diet-treated non-insulin-dependent diabetes: Role of dyslipidaemia
16. Intensive blood-glucose control with sulphonyureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
17. Endothelium-dependent flow-mediated vasodilation in the postprandial state in type 2 diabetes mellitus
18. Endothelial dysfunction and pathogenesis of diabetic angiopathy
19. Dyslipoproteinaemia and hyperoxidative stress in the pathogenesis of endothelial dysfunction in non-insulin dependent diabetes mellitus: An hypothesis
20. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo
21. Activation of protein kinase C by elevation of glucose concentration: Proposal for a mechanism in the development of diabetic vascular complications
22. Hemoglobin-AGE: A circulating marker of advanced glycosylation
23. Lipid advanced glycosylation: Pathway for lipid oxidation in vivo
24. Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor
25. Ascorbate restores endothelium-dependent vasodilatation impaired by acute hyperglycemia in humans
26. NIDDM as a disease of the innate immune system: Association of acute-phase reactants and interleukin-6 with metabolic syndrome X
27. C-reactive protein, a sensitive marker of inflammation, predicts further risk of coronary heart disease in initially healthy middle-aged men: Results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort study, 1984 to 1992
28. Novel inflammatory markers of coronary risk: Theory versus practice
29. C-reactive protein in healthy subjects: Association with obesity, insulin resistance, and endothelial dysfunction. A potential role for cytokines originating from adipose tissue?
30. Elevated C-reactive protein: Another component of the atherothrombotic profile of abdominal obesity